RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Return
24.59%
This Quarter Return
-2.97%
1 Year Return
+24.59%
3 Year Return
+106.81%
5 Year Return
+195.15%
10 Year Return
+469.64%
AUM
$107B
AUM Growth
-$4.88B
(-4.4%)
Cap. Flow
+$738M
Cap. Flow
% of AUM
0.69%
Top 10 Holdings %
Top 10 Hldgs %
28.03%
Holding
4,263
New
45
Increased
1,724
Reduced
2,096
Closed
86
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$72.4M |
| 2 |
Visa
V
|
+$47.8M |
| 3 |
DoorDash
DASH
|
+$43.8M |
| 4 |
Apple
AAPL
|
+$43.6M |
| 5 |
XYZ
Block, Inc.
XYZ
|
+$35.9M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$70.4M |
| 2 |
EXE
Expand Energy Corporation Common Stock
EXE
|
+$24.8M |
| 3 |
Exxon Mobil
XOM
|
+$20.4M |
| 4 |
AZPN
Aspen Technology Inc
AZPN
|
+$19.7M |
| 5 |
ALTR
Altair Engineering Inc. Class A Common Stock
ALTR
|
+$19.5M |
Sector Composition
| 1 | Technology | 28.7% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 10.95% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3001
FuelCell Energy
FCEL
$209M
| $147K | ﹤0.01% |
32,012
+5,585
| +21% | +$25.6K |
|
3002
Townsquare Media
TSQ
$115M
| $147K | ﹤0.01% |
18,036
+3,393
| +23% | +$27.6K |
|
3003
Kodiak Sciences
KOD
$524M
| $147K | ﹤0.01% |
52,274
+805
| +2% | +$2.26K |
|
3004
Stratus Properties
STRS
$161M
| $146K | ﹤0.01% |
8,245
-21
| -0.3% | -$373 |
|
3005
New Oriental
EDU
$8.93B
| $146K | ﹤0.01% |
3,054
-1,810
| -37% | -$86.5K |
|
3006
Solid Biosciences
SLDB
$413M
| $146K | ﹤0.01% |
39,422
-4,255
| -10% | -$15.7K |
|
3007
eGain
EGAN
$219M
| $145K | ﹤0.01% |
29,950
+1,266
| +4% | +$6.14K |
|
3008
LINKBANCORP
LNKB
$271M
| $145K | ﹤0.01% |
21,424
-1,377
| -6% | -$9.34K |
|
3009
BRC Inc
BRCC
$189M
| $144K | ﹤0.01% |
69,066
+2,317
| +3% | +$4.84K |
|
3010
Adverum Biotechnologies
ADVM
$65.9M
| $144K | ﹤0.01% |
32,999
+1,332
| +4% | +$5.82K |
|
|
RAPP
3011
Rapport Therapeutics
RAPP
$847M
| $144K | ﹤0.01% |
14,358
+4,109
| +40% | +$41.2K |
|
3012
Nkarta
NKTX
$147M
| $144K | ﹤0.01% |
78,185
-3,006
| -4% | -$5.53K |
|
3013
Editas Medicine
EDIT
$244M
| $144K | ﹤0.01% |
123,850
-16,867
| -12% | -$19.6K |
|
3014
Alector
ALEC
$290M
| $143K | ﹤0.01% |
116,635
+740
| +0.6% | +$910 |
|
3015
C4 Therapeutics
CCCC
$194M
| $143K | ﹤0.01% |
89,633
-10,382
| -10% | -$16.6K |
|
3016
Sonida Senior Living
SNDA
$490M
| $143K | ﹤0.01% |
6,125
+1,681
| +38% | +$39.1K |
|
3017
AMES National
ATLO
$184M
| $142K | ﹤0.01% |
8,112
-754
| -9% | -$13.2K |
|
3018
Larimar Therapeutics
LRMR
$357M
| $140K | ﹤0.01% |
65,018
+8,818
| +16% | +$19K |
|
3019
Criteo
CRTO
$1.15B
| $138K | ﹤0.01% |
3,908
-226
| -5% | -$8K |
|
3020
Orchestra BioMed
OBIO
$141M
| $135K | ﹤0.01% |
31,657
+914
| +3% | +$3.91K |
|
3021
Gencor Industries
GENC
$228M
| $135K | ﹤0.01% |
11,140
-1,501
| -12% | -$18.3K |
|
3022
scPharmaceuticals
SCPH
$302M
| $135K | ﹤0.01% |
51,499
+8,945
| +21% | +$23.5K |
|
|
SEPN
3023
Septerna, Inc. Common Stock
SEPN
$643M
| $135K | ﹤0.01% |
23,318
+3,323
| +17% | +$19.2K |
|
3024
Zentalis Pharmaceuticals
ZNTL
$113M
| $134K | ﹤0.01% |
84,542
-7,672
| -8% | -$12.2K |
|
3025
Smith-Midland
SMID
$221M
| $133K | ﹤0.01% |
4,265
+372
| +10% | +$11.6K |
|